8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)
Published . Updated .
Filed: 2026-10-19 AccNo: 0001493152-26-047601 Size: 412 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- VVOS Vivos Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-19 AccNo: 0001493152-26-047601 Size: 412 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 3.03: Ma…
Source: sec-edgar
Price since this story was published: Vivos Therapeutics (VVOS)
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.52% | final price |
| GLD | three days earlier | +0.80% | final price |
| GLD | five days earlier | +0.53% | final price |
| QQQ | that day | -0.15% | final price |
| QQQ | three days earlier | +1.38% | final price |
| QQQ | five days earlier | +3.53% | final price |
| SPY | that day | +0.32% | final price |
| SPY | three days earlier | +0.67% | final price |
| SPY | five days earlier | +1.49% | final price |
| TLT | that day | +0.83% | final price |
| TLT | three days earlier | +0.67% | final price |
| TLT | five days earlier | -1.40% | final price |
| Vivos Therapeutics (VVOS) | that day | +3.13% | final price |
| Vivos Therapeutics (VVOS) | three days earlier | +4.54% | final price |
| Vivos Therapeutics (VVOS) | five days earlier | +2.46% | final price |
Who gains and who loses around Vivos Therapeutics (VVOS)
Companies mentioned with this story
- VVOS Vivos Therapeutics
In “8-K - Vivos Therapeutics, Inc. (0001716166) (Filer),” Vivos Therapeutics (VVOS) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> VVOS
How “8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)” reaches Vivos Therapeutics (VVOS)
On 19 Oct 2026, “8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)” is the story that connects Vivos Therapeutics (VVOS) to this story.
For Vivos Therapeutics (VVOS), the reason on file says SEC 8-K filing -> direct issuer disclosure -> VVOS
Dates and price levels for Vivos Therapeutics (VVOS)
VVOS traded between 0.12 and 0.15 across 3 sessions. The latest close on file is 0.13.
What the saved facts support for Vivos Therapeutics (VVOS)
34 out of 100
“8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)” scores 34 out of 100. The score uses 1 sources, a +2.81% difference versus the S&P 500 (SPY), and 1 linked companies.